Pharma BD Deal Intelligence
Stryker acquired Wright Medical for $30.75 per share, representing total equity value of approximately $4 billion and enterprise value of approximately $5.4 billion including convertible notes. The deal strengthened Stryker's extremities and biologics portfolio.
| Deal | Year | Value | Outcome |
|---|---|---|---|
| Stryker Corporation / Wright Medical Group N.V. (this deal) | 2019 | $5.4B | 81 |
| Stryker Corporation / MAKO Surgical Corp. | 2013 | $1.6B | 91 |
| Stryker Corporation / Gaymar Industries | 2010 | $150M | 54 |
| Stryker Corporation / Trauson Holdings Company Limited | 2013 | $764M | 37 |
| Stryker Corporation / Inari Medical, Inc. | 2025 | $4.9B | — |
| AstraZeneca PLC / Daiichi Sankyo Company, Limited | 2019 | $6.9B | 100 |
| Novo Nordisk A/S / Dicerna Pharmaceuticals, Inc. | 2019 | $3.3B | 88 |
← Browse all deals · How we score deals
More: 2019 deals · Stryker Corporation deals